For Staphylococcus bacteremia, is a line holiday sufficient or should the catheter be removed and exchanged for a new site?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Staph Bacteremia and Central Line Management

For Staphylococcus aureus catheter-related bloodstream infection (CRBSI), the infected catheter should always be removed and a temporary catheter inserted at a new anatomical site—a "line holiday" or simple exchange is not sufficient. 1

The Evidence-Based Approach

For Hemodialysis Catheters with S. aureus CRBSI

The IDSA guidelines are unequivocal: The infected catheter should always be removed for patients with hemodialysis CRBSI due to S. aureus (Grade A-II recommendation). 1 A temporary (non-tunneled) catheter should be inserted into a different anatomical site—not the same site, not over a guidewire at the same location. 1

The only exception is when absolutely no alternative sites are available for catheter insertion—only then should you exchange the infected catheter over a guidewire. 1 This is a last-resort measure, not standard practice.

For Non-Hemodialysis Central Lines

Short-term catheters should be removed immediately for patients with S. aureus CRBSI (Grade A-II). 1 For long-term catheters, removal is strongly recommended unless there are major contraindications such as no alternative venous access, significant bleeding diathesis, or quality-of-life considerations that outweigh the need for reinsertion. 1

Why Removal is Critical

The mortality and morbidity data are compelling:

  • Delayed catheter removal is associated with persistent bacteremia (p = 0.01) 2
  • Patients with S. aureus bacteremia who retain their catheters have higher overall mortality compared to those whose catheters are exchanged or removed (p = 0.034) 3
  • Prolonged S. aureus bacteremia (≥48 hours) carries a 90-day mortality risk of 39% 4
  • S. aureus causes metastatic infection in more than one-third of cases, including endocarditis (12%), septic arthritis (7%), and vertebral osteomyelitis (4%) 4

Timing of New Catheter Placement

A new long-term catheter can be placed once blood cultures show negative results. 1 After catheter removal, placement of a new catheter can proceed when additional blood cultures show no growth. 1

The Contrast with Other Organisms

This aggressive approach is specific to S. aureus (and Pseudomonas species and Candida). For other pathogens like coagulase-negative staphylococci or non-Pseudomonas gram-negative bacilli, catheter retention with antibiotic therapy may be attempted if symptoms resolve within 2-3 days and there's no metastatic infection. 1

Common Pitfalls to Avoid

  1. Don't attempt guidewire exchange as routine practice for S. aureus CRBSI—this is only for situations with no alternative access sites
  2. Don't delay removal waiting for culture results—if S. aureus bacteremia is suspected from a line, act promptly
  3. Don't underestimate the risk of complications—failure or delay in catheter removal increases risk of hematogenous complications and mortality 5
  4. Don't forget source control—removing the catheter is as important as antibiotic selection for achieving cure 6

Antibiotic Duration

After catheter removal, patients require 4-6 weeks of antimicrobial therapy unless they meet specific criteria for shorter treatment (≥14 days), which includes: non-diabetic, non-immunosuppressed, catheter removed, no prosthetic devices, negative TEE, fever/bacteremia resolution within 72 hours, and no metastatic infection. 1

Related Questions

In Staphylococcus aureus bacteremia, should a tunneled catheter be removed promptly due to biofilm formation, and what is the recommended antibiotic regimen?
What is the appropriate management of a local infection of a left‑arm peripherally inserted central catheter (PICC) line in a patient who had a Staphylococcus aureus infection of the contralateral arm PICC three months ago, with no laboratory evidence of sepsis?
In a 77‑year‑old woman with prior Staphylococcus epidermidis bacteremia treated two months ago who now has four months of intermittent sweating and chills, what diagnostic tests should be performed to assess for persistent infection or other causes?
What is the appropriate management for an abscess infected with Staphylococcus aureus?
In a 20-year-old man with methicillin‑resistant Staphylococcus aureus (MRSA) bacteremia and an ultrasound‑confirmed thrombus in the right basilic vein associated with a peripherally inserted central catheter (PICC) line, what is the appropriate next step in management in addition to initiating anti‑MRSA antibiotics?
What is the Society for Fetal Urology (SFU) grading system in antenatal hydronephrosis?
Is Movantik (naloxegol) appropriate for treating constipation in a patient with pancreatic bowel obstruction?
What is the therapeutic plasma concentration range of promethazine?
What are the differences between Enterococcus faecalis and Enterococcus faecium regarding antimicrobial susceptibility and recommended treatment?
What are seizures caused by cerebral hypoperfusion due to hypotension called?
What does a cholestatic R factor indicate, and what are the recommended evaluation and management steps?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.